Maria Ribecco-Lutkiewicz

Title: Maria Ribecco-Lutkiewicz: Innovator in Blood-Brain Barrier Research

Introduction

Maria Ribecco-Lutkiewicz is a prominent inventor based in Ottawa, Canada. She has made significant contributions to the field of biomedical research, particularly in the study of the blood-brain barrier. Her innovative work has led to the development of a unique in vitro model that aids in understanding the complexities of this critical barrier.

Latest Patents

Maria holds a patent for her invention titled "Human blood brain barrier model." This patent describes an in vitro population of human brain endothelial cells (hBECs) that express key proteins such as claudin-5, occludin, ZO-1, and GLUT-1. Additionally, these cells express one or more of FZD7, WNT7A, WNT7B, APCDD1, STRA6, and ZO-3. The patent outlines a blood-brain barrier (BBB) comprising these hBECs and discusses the use of this model for analyzing the permeability characteristics of various test agents.

Career Highlights

Maria is affiliated with the National Research Council of Canada, where she continues to advance her research. Her work is pivotal in the field of neuroscience and pharmacology, providing insights that could lead to better therapeutic strategies for neurological disorders.

Collaborations

Maria collaborates with esteemed colleagues, including Mahmud Bani and Danica Stanimirovic. Their combined expertise enhances the research efforts at the National Research Council of Canada.

Conclusion

Maria Ribecco-Lutkiewicz is a trailblazer in blood-brain barrier research, with her innovative patent contributing to the understanding of this vital area in medical science. Her work exemplifies the importance of research in developing new therapeutic approaches.